Cite

HARVARD Citation

    Visacri, M. et al. (2022). Adverse reactions and adherence to capecitabine: A prospective study in patients with gastrointestinal cancer. Journal of oncology pharmacy practice. pp. 326-336. [Online]. 
  
Back to record